Francesca Micoli Selected Research

Infections

3/2024	Vaccine value profile for Klebsiella pneumoniae.
3/2024	Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine.
7/2023	Elucidating the role of N-acetylglucosamine in Group A Carbohydrate for the development of an effective glycoconjugate vaccine against Group A Streptococcus.
1/2023	Functional assays to evaluate antibody-mediated responses against Shigella: a review.
1/2023	Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses.
4/2021	Prophylaxis and Treatment against Klebsiella pneumoniae: Current Insights on This Emerging Anti-Microbial Resistant Global Threat.
1/2021	Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA).
1/2020	Structure, dynamics and immunogenicity of a catalytically inactive CXC chemokine-degrading protease SpyCEP from Streptococcus pyogenes.
1/2020	Gold nanoparticles morphology does not affect the multivalent presentation and antibody recognition of Group A Streptococcus synthetic oligorhamnans.
1/2018	IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal Salmonella Develop at Discordant Rates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesca Micoli Research Topics

Disease

14	Bacillary Dysentery (Shigellosis) 04/2024 - 06/2020
10	Infections 03/2024 - 01/2018
6	Communicable Diseases (Infectious Diseases) 11/2023 - 01/2019
6	Typhoid Fever (Typhoid) 01/2023 - 01/2011
3	Meningitis 10/2023 - 11/2013
3	Bacterial Infections (Bacterial Infection) 09/2022 - 01/2021
3	Sepsis (Septicemia) 01/2022 - 01/2015
3	Blister (Bulla) 06/2021 - 03/2015
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Paratyphoid Fever 01/2024
1	Neoplasms (Cancer) 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Malaria 01/2023
1	Pneumococcal Infections 01/2023
1	Rabies (Hydrophobia) 11/2022
1	Vaccine-Preventable Diseases 02/2022
1	Meningococcal Infections 01/2021
1	Impetigo (Impetigo Contagiosa) 11/2020
1	Hemolysis 11/2020
1	Pharyngitis (Sore Throat) 11/2020
1	Haemophilus Infections 01/2020
1	Salmonella Infections (Salmonellosis) 10/2018
1	Meningococcal Meningitis 11/2013
1	Pain (Aches) 01/2011

Drug/Important Bio-Agent (IBA)

36	VaccinesIBA 04/2024 - 01/2011
9	Polysaccharides (Glycans)IBA 11/2023 - 01/2011
8	glyceryl methyl methacrylateIBA 03/2024 - 01/2018
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2015
7	AntibodiesIBA 01/2024 - 01/2016
7	GlycoconjugatesIBA 11/2023 - 11/2013
6	O Antigens (O Antigen)IBA 01/2024 - 10/2018
4	Immunoglobulin G (IgG)IBA 03/2024 - 01/2018
4	Conjugate VaccinesIBA 01/2023 - 01/2011
3	LipopolysaccharidesIBA 03/2024 - 02/2022
3	AntigensIBA 03/2024 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 01/2021
2	CarbohydratesIBA 07/2023 - 01/2021
1	Carrier Proteins (Binding Protein)IBA 07/2023
1	Toll-Like Receptor AgonistsIBA 01/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 11/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2021
1	Virulence Factors (Pathogenicity Factors)IBA 04/2021
1	SiderophoresIBA 04/2021
1	Interleukin-8 (Interleukin 8)IBA 11/2020
1	CRM197 (non-toxic variant of diphtheria toxin)IBA 10/2018
1	Bacterial AntigensIBA 01/2018

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 03/2024
1	Operative Surgical Procedures 03/2024
1	Critical Care (Surgical Intensive Care) 03/2024